Search

Home > Breast Cancer Update > SABCS Spin-Off | 06 - Hudis
Podcast: Breast Cancer Update
Episode:

SABCS Spin-Off | 06 - Hudis
Category: Science & Medicine
Duration: 00:15:12
Publish Date: 2007-03-16 15:55:23
Description: Outside a protocol setting, dose-dense AC ->paclitaxel, administered every two weeks with growth factors, with trastuzumab during and following the paclitaxel, provides the best potential risk/benefit profile for women with HER2-positive, node-positive disease.
Total Play: 0

Users also like

70+ Episodes
The Expert V .. 7     1

Some more Podcasts by Dr. Neil Love

600+ Episodes
Hematologic .. 50+     9
600+ Episodes
Lung Cancer ..    
300+ Episodes
Gastrointest .. 7     3